Minimally invasive direct lateral interbody fusion in the treatment of the thoracic and lumbar spinal tuberculosisMini-DLIF for the thoracic and lumbar spinal tuberculosis

Autor: Haitao Tan, Ying Li, Jianzhong Jiang, Guoping Chen, Zhaolin Xie, Shengbin Huang, Fengping Gan
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Adult
Male
medicine.medical_specialty
Time Factors
lcsh:Diseases of the musculoskeletal system
Sports medicine
Visual analogue scale
medicine.medical_treatment
Antitubercular Agents
Bone grafting
Thigh
Thoracic Vertebrae
03 medical and health sciences
0302 clinical medicine
Lumbar
Rheumatology
Minimally invasive surgery
Internal medicine
medicine
Humans
Minimally Invasive Surgical Procedures
Orthopedics and Sports Medicine
Direct lateral interbody fusion (DLIF)
030212 general & internal medicine
Aged
Thoracic and lumbar spinal tuberculosis
Bone Transplantation
Lumbar Vertebrae
business.industry
Recovery of Function
Middle Aged
Magnetic Resonance Imaging
Surgery
Spinal Fusion
Treatment Outcome
medicine.anatomical_structure
Debridement
Orthopedic surgery
Thoracic vertebrae
Female
Tuberculosis
Spinal
lcsh:RC925-935
Tomography
X-Ray Computed
business
030217 neurology & neurosurgery
Research Article
Zdroj: BMC Musculoskeletal Disorders, Vol 19, Iss 1, Pp 1-8 (2018)
BMC Musculoskeletal Disorders
ISSN: 1471-2474
Popis: Background To investigate the clinical efficacy of minimally invasive direct lateral approach debridement, interbody bone grafting, and interbody fusion in the treatment of the thoracic and lumbar spinal tuberculosis. Methods From January 2013 to January 2016, 35 cases with thoracic and lumbar spinal tuberculosis received direct lateral approach debridement, interbody bone grafting, and interbody fusion. Of the 35 cases, 16 patients were male and 19 were female and the median age was 55.2 (range 25–83). The affected segments were single interspace, and the involved vertebral bodies included: 15 cases of thoracic vertebrae (1 cases of T5/6, 2 cases of T6/7, 4 cases of T7/8, 3 cases of T8/9, 5 cases of T9/10) and 20 cases of lumbar spine (2 cases of L1/2, 6 cases of L2/3, 6 cases of L3/4, 6 cases of L4/5). After MIDLIF operation, all the patients received medication of four anti-tubercular drugs for 12 to18 months. Results The patients were followed up for 7 to 40 months with an average of 18.5 months. The visual analogue scale (VAS) at the last follow-up was 2.8 ± 0.5, which was significantly different from the preoperative VAS (8.2 ± 0.7). After MIDLIF, there was 5 cases occurred with transient numbness in one side of the thigh or inguinal region, and 10 cases suffered from flexion hip weakness. All the bone grafts were fused within 6~ 18 months (average of 11.5 months) after the operation. Conclusion Minimally invasive lateral approach interbody fusion technology have the advantage of less injury and quick recovery after surgery, which is the effective and safe treatment for thoracic and lumbar spinal tuberculosis.
Databáze: OpenAIRE
Externí odkaz: